Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04275700 · ClinicalTrials.gov registry record · NA
Study of PRP in Women With Evidence of Diminished Ovarian Reserve
A NA study of Diminished Ovarian Reserve and Ovarian Failure, sponsored by Center for Human Reproduction.
- Completed
- Registry status
- NA
- Development phase
- 80
- Enrollment target
- 1
- Study location
NCT04275700 is a NA study of Diminished Ovarian Reserve and Ovarian Failure that has completed, run by Center for Human Reproduction. The registered enrollment target is 80 participants. The trial reports 1 study location across 1 state.
The verdict
NCT04275700, a NA study of Diminished Ovarian Reserve and Ovarian Failure, has completed, sponsored by Center for Human Reproduction.
- COMPLETED
- Registry status
- NA
- Development phase
- 80 participants
- Enrollment target
- 1
- Study location
Study Summary
The hypothesis of the study is that ovaries of women with a history of poor response to ovulation induction may benefit from exposure to growth factors known to be present in Platelet Rich Plasma (PRP). Since even ovaries from women with poor response still contain primordial follicles (which, however, no longer undergo recruitment), it is hoped that PRP injections into ovaries will activate follicular recruitment pathways and, subsequently, result in follicle growth. Should such growth be observed, follicles will be supported with routine daily gonadotropin stimulation until hCG trigger.
Conditions Studied
Interventions
- PROCEDURE A-PRP
Study Locations (1)
New York
- Center For Human Reproduction - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2018-10-01 |
| Est. Completion | 2024-09-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04275700
The ClinicalTrials.gov registry entry for NCT04275700 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Center for Human Reproduction, which has 8 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Diminished Ovarian Reserve appearing as the primary indexed condition, and to 1 intervention - of which A-PRP is the first listed.
NCT04275700 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT04275700 about?
NCT04275700 is a clinical study titled "Study of PRP in Women With Evidence of Diminished Ovarian Reserve". The hypothesis of the study is that ovaries of women with a history of poor response to ovulation induction may benefit from exposure to growth factors known to be present in Platelet Rich Plasma (PRP). Since even ovaries from women with poor response still contain primordial follicles (which, howev...
What is the current status of trial NCT04275700?
This trial is currently completed. It is a NA study. The enrollment target is 80 participants. The study started on 2018-10-01. Estimated completion is 2024-09-01.
What conditions does trial NCT04275700 study?
This clinical trial studies the following conditions: Diminished Ovarian Reserve, Ovarian Failure.
What interventions are being tested in trial NCT04275700?
The interventions under investigation include: A-PRP (PROCEDURE).
Who is sponsoring clinical trial NCT04275700?
This trial is sponsored by Center for Human Reproduction, which has 8 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04275700 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diminished Ovarian Reserve
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.